OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic Review and Network Meta-Analysis of Overall Survival Comparing 3 mg/kg Ipilimumab With Alternative Therapies in the Management of Pretreated Patients With Unresectable Stage III or IV Melanoma
P. Dequen, Paul Lorigan, Jeroen P. Jansen, et al.
The Oncologist (2012) Vol. 17, Iss. 11, pp. 1376-1385
Open Access | Times Cited: 28
P. Dequen, Paul Lorigan, Jeroen P. Jansen, et al.
The Oncologist (2012) Vol. 17, Iss. 11, pp. 1376-1385
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash
Neelima N. Nallapaneni, Rajesh Mourya, Vijaya Raj Bhatt, et al.
Journal of the National Comprehensive Cancer Network (2014) Vol. 12, Iss. 8, pp. 1077-1081
Open Access | Times Cited: 72
Neelima N. Nallapaneni, Rajesh Mourya, Vijaya Raj Bhatt, et al.
Journal of the National Comprehensive Cancer Network (2014) Vol. 12, Iss. 8, pp. 1077-1081
Open Access | Times Cited: 72
PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis
Hao Wu, Liming Xia, Dong-Dong Jia, et al.
Molecular Immunology (2020) Vol. 119, pp. 83-91
Closed Access | Times Cited: 54
Hao Wu, Liming Xia, Dong-Dong Jia, et al.
Molecular Immunology (2020) Vol. 119, pp. 83-91
Closed Access | Times Cited: 54
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
Adam Karlsson, Sohag N. Saleh
Clinical Cosmetic and Investigational Dermatology (2017) Vol. Volume 10, pp. 325-339
Open Access | Times Cited: 60
Adam Karlsson, Sohag N. Saleh
Clinical Cosmetic and Investigational Dermatology (2017) Vol. Volume 10, pp. 325-339
Open Access | Times Cited: 60
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
Victor Barzey, Michael B. Atkins, Louis P. Garrison, et al.
Journal of Medical Economics (2012) Vol. 16, Iss. 2, pp. 202-212
Closed Access | Times Cited: 49
Victor Barzey, Michael B. Atkins, Louis P. Garrison, et al.
Journal of Medical Economics (2012) Vol. 16, Iss. 2, pp. 202-212
Closed Access | Times Cited: 49
Putative role of HIF transcriptional activity in melanocytes and melanoma biology
Blazej Zbytek, Danielle L. Peacock, Tiffany N. Seagroves, et al.
Dermato-Endocrinology (2013) Vol. 5, Iss. 2, pp. 239-251
Open Access | Times Cited: 48
Blazej Zbytek, Danielle L. Peacock, Tiffany N. Seagroves, et al.
Dermato-Endocrinology (2013) Vol. 5, Iss. 2, pp. 239-251
Open Access | Times Cited: 48
PD-L1 expression in papillary renal cell carcinoma
Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, et al.
BMC Urology (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 43
Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, et al.
BMC Urology (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 43
A systematic review of survival following anti-cancer treatment for small cell lung cancer
G. Jones, Kelly Elimian, David Baldwin, et al.
Lung Cancer (2020) Vol. 141, pp. 44-55
Open Access | Times Cited: 37
G. Jones, Kelly Elimian, David Baldwin, et al.
Lung Cancer (2020) Vol. 141, pp. 44-55
Open Access | Times Cited: 37
Complications of bone metastases from malignant melanoma
Jamal Zekri, Maria Marples, Dominic Taylor, et al.
Journal of bone oncology (2017) Vol. 8, pp. 13-17
Open Access | Times Cited: 33
Jamal Zekri, Maria Marples, Dominic Taylor, et al.
Journal of bone oncology (2017) Vol. 8, pp. 13-17
Open Access | Times Cited: 33
A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions
Miguel Ángel Martínez‐García, Erica Riveiro‐Falkenbach, José Luis Rodríguez‐Peralto, et al.
Melanoma Research (2017) Vol. 27, Iss. 6, pp. 558-564
Closed Access | Times Cited: 25
Miguel Ángel Martínez‐García, Erica Riveiro‐Falkenbach, José Luis Rodríguez‐Peralto, et al.
Melanoma Research (2017) Vol. 27, Iss. 6, pp. 558-564
Closed Access | Times Cited: 25
A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidence
John Stevens, Christine Fletcher, Gerald Downey, et al.
Research Synthesis Methods (2017) Vol. 9, Iss. 2, pp. 148-162
Open Access | Times Cited: 24
John Stevens, Christine Fletcher, Gerald Downey, et al.
Research Synthesis Methods (2017) Vol. 9, Iss. 2, pp. 148-162
Open Access | Times Cited: 24
Radiation therapy for melanoma brain metastases: a systematic review
John F. Thompson, Gabrielle Williams, Angela Hong
Radiology and Oncology (2022) Vol. 56, Iss. 3, pp. 267-284
Open Access | Times Cited: 11
John F. Thompson, Gabrielle Williams, Angela Hong
Radiology and Oncology (2022) Vol. 56, Iss. 3, pp. 267-284
Open Access | Times Cited: 11
In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma.
Qiuhong Yang, Daniel Aires, Shuang Cai, et al.
PubMed (2014) Vol. 13, Iss. 3, pp. 283-7
Closed Access | Times Cited: 16
Qiuhong Yang, Daniel Aires, Shuang Cai, et al.
PubMed (2014) Vol. 13, Iss. 3, pp. 283-7
Closed Access | Times Cited: 16
<p>Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma</p>
Junichi Inokuchi, Masatoshi Eto
Cancer Management and Research (2019) Vol. Volume 11, pp. 4519-4528
Open Access | Times Cited: 14
Junichi Inokuchi, Masatoshi Eto
Cancer Management and Research (2019) Vol. Volume 11, pp. 4519-4528
Open Access | Times Cited: 14
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Jordan Amdahl, Lei Chen, Thomas E. Delea
Oncology and Therapy (2016) Vol. 4, Iss. 2, pp. 239-256
Open Access | Times Cited: 9
Jordan Amdahl, Lei Chen, Thomas E. Delea
Oncology and Therapy (2016) Vol. 4, Iss. 2, pp. 239-256
Open Access | Times Cited: 9
Immunotherapy in Advanced Melanoma: A Network Meta-Analysis
Jung‐Soo Pyo, Guhyun Kang
Immunotherapy (2017) Vol. 9, Iss. 6, pp. 471-479
Closed Access | Times Cited: 9
Jung‐Soo Pyo, Guhyun Kang
Immunotherapy (2017) Vol. 9, Iss. 6, pp. 471-479
Closed Access | Times Cited: 9
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
Casey Quinn, Qiufei Ma, Amber Kudlac, et al.
Advances in Therapy (2016) Vol. 34, Iss. 2, pp. 495-512
Open Access | Times Cited: 6
Casey Quinn, Qiufei Ma, Amber Kudlac, et al.
Advances in Therapy (2016) Vol. 34, Iss. 2, pp. 495-512
Open Access | Times Cited: 6
Common Skin Diseases
Tuyen T. L. Nguyen, Eric Tarapore, Scott X. Atwood
(2019), pp. 83-103
Closed Access | Times Cited: 6
Tuyen T. L. Nguyen, Eric Tarapore, Scott X. Atwood
(2019), pp. 83-103
Closed Access | Times Cited: 6
Manipulating Immune Regulatory Pathways to Enhance T Cell Stimulation
Joeri J. Pen, Joeri L. Aerts, Thérèse Liechtenstein, et al.
InTech eBooks (2014)
Open Access | Times Cited: 5
Joeri J. Pen, Joeri L. Aerts, Thérèse Liechtenstein, et al.
InTech eBooks (2014)
Open Access | Times Cited: 5
Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access Program
Bernardo L. Rapoport, Daniel Vorobiof, Lydia Dreosti, et al.
Journal of Global Oncology (2017) Vol. 3, Iss. 5, pp. 515-523
Open Access | Times Cited: 5
Bernardo L. Rapoport, Daniel Vorobiof, Lydia Dreosti, et al.
Journal of Global Oncology (2017) Vol. 3, Iss. 5, pp. 515-523
Open Access | Times Cited: 5
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment
Lieke van Montfort, Caroline M.J. Loos, Monique Anten, et al.
Case Reports in Oncology (2017) Vol. 10, Iss. 3, pp. 1112-1115
Open Access | Times Cited: 5
Lieke van Montfort, Caroline M.J. Loos, Monique Anten, et al.
Case Reports in Oncology (2017) Vol. 10, Iss. 3, pp. 1112-1115
Open Access | Times Cited: 5
A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013
Frederick Morgan, Juanita Duran, Bélen Fraile, et al.
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 5, pp. 921-928
Closed Access | Times Cited: 4
Frederick Morgan, Juanita Duran, Bélen Fraile, et al.
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 5, pp. 921-928
Closed Access | Times Cited: 4
Ipilimumab: a guide to its use in advanced melanoma in the EU
Katherine A. Lyseng‐Williamson
Drugs & Therapy Perspectives (2014) Vol. 30, Iss. 4, pp. 124-129
Closed Access | Times Cited: 1
Katherine A. Lyseng‐Williamson
Drugs & Therapy Perspectives (2014) Vol. 30, Iss. 4, pp. 124-129
Closed Access | Times Cited: 1
Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
Alexander Dillon, Kevin Lin, Andrew Kwong, et al.
AIMS Public Health (2015) Vol. 2, Iss. 1, pp. 86-114
Open Access | Times Cited: 1
Alexander Dillon, Kevin Lin, Andrew Kwong, et al.
AIMS Public Health (2015) Vol. 2, Iss. 1, pp. 86-114
Open Access | Times Cited: 1
